(Q24234115)

6

0 references

Suetonia Palmer

3

0 references

Jonathan Craig

4

Jonathan C Craig

0 references

Giovanni Strippoli

9

Giovanni FM Strippoli

0 references

Angela Webster

7

Angela C Webster

0 references

Lucia Di Micco

2

Lucia Di Micco

0 references

Mona Razavian

1

Mona Razavian

0 references

Meg Jardine

8

Cochrane Database of Systematic Reviews

Meg J Jardine

0 references

publication date

10 November 2010

0 references

published in

0 references

cites work

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Cardiovascular Mortality in End-Stage Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Congestive heart failure in chronic kidney disease: disease-specific mechanisms of systolic and diastolic heart failure and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Pathophysiology of cardiovascular disease and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

The burden of adult hypertension in the United States 1999 to 2000: a rising tide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Chronic renal failure: a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Platelet dysfunction and end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

The case of the misleading funnel plot

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Long-term survival in renal transplant recipients with graft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Cardiac problems in the dialysis patient: beyond coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Bleeding in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Medications in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Meta-analysis of antiplatelet therapy for IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Chronic kidney disease increases risk for venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Kidney disease as a risk factor for recurrent cardiovascular disease and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

7 January 2021

Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

7 January 2021

Cardiovascular morbidity and risk factors in renal transplant patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

7 January 2021

Effect of aspirin and dipyridamole on proteinuria in idiopathic membranoproliferative glomerulonephritis: a multicentre prospective clinical trial. Collaborative Glomerulonephritis Therapy Study Group (CGTS)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

7 January 2021

Defects in platelet adhesion and aggregate formation in uremic bleeding disorder can be attributed to factors in plasma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

7 January 2021

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

7 January 2021

Meta-analysis: vitamin D compounds in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008834

7 January 2021

10.1002/14651858.CD008834

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3377179

OpenCitations bibliographic resource ID

3377179

1 reference